These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2004-004231-53 The Effect Of Antihypertensive Treatment With Lisinopril and Labetalol on Baroreflex Sensitivity in Stroke 2010-05-30 due-trials
Not reported 2005-000656-33 A Phase I/II Study of Sirolimus (Rapamune TM) in Combination with Cyclophosphamide and Dexamethasone in Relapsed Myeloma 2009-06-10 due-trials
Completed, but no date Terminated 2005-002247-86 Peripheral Blood Stem Cell Mobilisation with Cyclophosphamide and Methylprednisolone in Patients with Myeloma and Indolent Lymphoma– a prospective single arm study with historical controls bad-data
Not reported 2006-001808-37 A randomised controlled trial of fentanyl versus morphine following lower limb arthroplasty 2009-05-30 due-trials
Not reported 2009-013100-32 Does modulating the gut hormones, incretins, modify vascular function, thereby reducing the risk of vascular complications in insulin resistant individuals? 2012-06-15 due-trials
Reported results 2010-019953-16 A Preliminary Randomised Controlled Trial using Standard Therapy Vs Mugard 2013-09-16 due-trials
Reported results 2010-023262-46 A Randomised Prospective Pilot Study Comparing the Outcomes of Patients with Lumbar Nerve Root Pain Secondary to Lumbar Disc Prolapse Treated by Nerve Root Block with or without the Addition of Clonid... 2014-08-14 due-trials
Not reported Terminated 2011-003572-36 The role of GLP-1 analogues in reducing reperfusion injury after acute stroke in patients with impaired swallowing. 2014-12-16 due-trials
Not reported 2015-002176-25 Do ultrasound guided botulinum A injections relieve pain in rotator cuff arthropathy? 2017-11-22 due-trials
Ongoing 2015-002790-38 TriMaster: Randomised Double-Blind Crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as third line therapy in patients with type 2 diabetes who have suboptimal glycaemic contr... not-yet-due
Reported results 2016-001530-10 A randomised controlled trial of topical intranasal tranexamic acid versus placebo to reduce the need for nasal packing in patients presenting to the Emergency Department with spontaneous epistaxis. 2019-07-22 due-trials